{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:35:42Z","timestamp":1791034542515,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ejphar.2011.04.002","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T15:08:29Z","timestamp":1302880109000},"page":"381-386","source":"Crossref","is-referenced-by-count":10,"title":["Intravenous administration of pravastatin immediately after middle cerebral artery occlusion reduces cerebral oedema in spontaneously hypertensive rats"],"prefix":"10.1016","volume":"660","author":[{"given":"Giuseppina","family":"Mariucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Tantucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Spaccatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.04.002_bb0005","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.STR.32.4.980","article-title":"Mavastatin an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice","volume":"32","author":"Amin-Hanjani","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainresrev.2007.10.010","article-title":"Neuroprotection by pravastatin in acute ischemic stroke in rats","volume":"58","author":"Berger","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0015","doi-asserted-by":"crossref","first-page":"C499","DOI":"10.1152\/ajpcell.00122.2003","article-title":"Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases","volume":"285","author":"Boo","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0020","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1471-4159.2004.02980.x","article-title":"Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones","volume":"92","author":"B\u00f6sel","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2010.02.036","article-title":"Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12\/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability","volume":"1325","author":"Cui","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neulet.2004.03.012","article-title":"Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces delayed neuronal death following transient forebrain ischemia in the adult rat hippocampus","volume":"362","author":"Daimon","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(94)90371-9","article-title":"Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging","volume":"254","author":"Elger","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0040","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.95.15.8880","article-title":"Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase","volume":"95","author":"Endres","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(01)01672-X","article-title":"Nitro-aspirin (NCX4016) reduces brain damage induced by focal cerebral ischemia in the rat","volume":"302","author":"Fredduzzi","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2004.01.015","article-title":"Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events","volume":"221","author":"Greisenegger","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0055","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0735-1097(98)00514-2","article-title":"Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions","volume":"33","author":"Kaesemeyer","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/01.STR.0000048213.18751.52","article-title":"HMG-CoA reductase inhibitor has protective effects against stroke events in stroke prone spontaneously hypertensive rats","volume":"34","author":"Kavashima","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neuroscience.2005.04.063","article-title":"Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1\/-2","volume":"134","author":"Kilic","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/HYPERTENSIONAHA.108.120584","volume":"53","author":"Kushiro","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0080","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/01.STR.31.10.2442","article-title":"Atorvastatin upreguaktes type III nitric oxide synthase in trhrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice","volume":"31","author":"Laufs","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(02)02649-5","article-title":"Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice","volume":"942","author":"Laufs","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0095","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/CIRCULATIONAHA.106.671826","article-title":"Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study)","volume":"117","author":"Mizuno","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1331.2007.02015.x","article-title":"Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial","volume":"15","author":"Montaner","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0110","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1476-5381.1992.tb13382.x","article-title":"L-arginine dilates rat pial arterioles by nitric oxide-dependent mechanisms and increases blood flow during focal cerebral ischaemia","volume":"107","author":"Morikawa","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1179\/174313206X153914","article-title":"Acute neurovascular unit protection by simvastatin in transient cerebral ischemia","volume":"28","author":"Nagaraja","year":"2006","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.STR.0000155732.27333.3c","article-title":"Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress","volume":"36","author":"Nagotani","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0125","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/STROKEAHA.107.492470","article-title":"Intravenous rosuvastatin for acute stroke treatment: an animal study","volume":"39","author":"Prinz","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0736-5748(93)90085-R","article-title":"Immunohistochemistry of glial reaction after injury in the rat: double stainings and markers of cell proliferation","volume":"11","author":"Schiffer","year":"1993","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0140","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.ATV.0000044458.23905.3B","article-title":"Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage","volume":"23","author":"Sironi","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0150","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/1073858405278321","article-title":"Reactive astrocytes in neural repair and protection","volume":"11","author":"Sofroniew","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainres.2007.08.069","article-title":"Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion","volume":"1181","author":"Sugiura","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0160","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jcbfm.1981.6","article-title":"Focal cerebral ischemia in the rat: 1. Description of techinque and early neuropatological consequences following middle cerebral artery occlusion","volume":"1","author":"Tamura","year":"1981","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0170","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1460-9568.2006.04920.x","article-title":"Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion","volume":"24","author":"Trinkl","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0175","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2010.01.030","article-title":"Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression","volume":"471","author":"Wang","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0180","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/01.RES.0000099503.13312.7B","article-title":"Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function","volume":"93","author":"Wassmann","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0185","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","author":"Williams","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0190","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.97.15.1440","article-title":"Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)","volume":"97","author":"WOSCOPS Study group","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000145327","article-title":"Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels","volume":"26","author":"Yemisci","year":"2008","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0200","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity","volume":"23","author":"Zacco","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0205","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1161\/CIRCULATIONAHA.104.516757","article-title":"Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat","volume":"112","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.04.002_bb0210","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/jcbfm.2009.105","article-title":"Atorvastatin extends the therapeutic window for tPA to 6h after the onset of embolic stroke in rats","volume":"29","author":"Zhang","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2011.04.002_bb0215","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. Basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ. J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911003669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911003669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T22:58:25Z","timestamp":1560121105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911003669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":43,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0014299911003669"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.04.002","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}